Телефон: +86 10 8048 4980 Почта: sales@accubiotech.com

Главная > Новости > Общественная информация

Accu-Tell® SARS-CoV-2 Ag Cassette for nasopharyngeal specimens is mutually recognized by EU Member States for public health measures

Nov. 01, 2021
Поделение мнений:

On 21 January 2021, EU Member States unanimously agreed on a Council Recommendation setting a common framework for the use of rapid antigen tests and the mutual recognition of COVID-19 test results across the EU. The Council Recommendation called on Member States to agree on three concrete deliverables, which includes a common list of COVID-19 rapid antigen tests that are considered appropriate for use in the context of the situations described in the Council Recommendation, that are in line with countries’ testing strategies.


A sixth update to the Common List was agreed by the Health Security Committee (HSC)  on 20 October 2021, among which Accu-Tell® SARS-CoV-2 Ag Cassette for nasopharyngeal specimens was listed.


The HSC agrees that, considering that all of the rapid antigen tests included in the EU common list are eligible for a test certificate issued as part of the EU Digital COVID Certificate, the entire list is considered to consist of rapid antigen tests of which Member States mutually recognise the test results for public health measures.

HSC List of SARS-CoV-2 Antigen Rapid Test.jpg